Synthesis and enantioselective enzymatic hydrolysis of rac-dimethylphenyl[1-(phenylacetamido)- ethyl]silane by Hengelsberg, H. et al.
Journal of Organametallic Chemistry, 415 (1991) 39-45 
Elsevier Sequoia S.A., Lausanne 
JOM 21852 
Synthesis and enantioselective enzymatic hydrolysis 
of rac-dimethylphenyl[l-(phenylacetamido)ethyl]silane 
Heidi Hengelsberg, Reinhold Tacke * 
Institut für Anorganische Chemie. Universität Karlsruhe, Engesserstraße, Geb. 30.45, 
W-7500 Karlsruhe I (Germany) 
Kirsten Fritsche, Christoph Syldatk and Fritz Wagner 
Institut für Biochemie und Biotechnologie A, Technische Universität Braunschweig, 
Konstantin-Uhde-Straße 5, W-3300 Braunschweig (Germany) 
(Received March 13th, 1991) 
Abstract 
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Racemic dimethylphenyl(l-(phenylacetamido)ethyl)silane [rac-5) has been made by a four-step 
synthesis starting from (chloromethyl)dimethylphenylsilane [PhMe2SiCH 2Cl (1) ~ PhMe2SiCH(Cl)Me 
(rac-2) - PhMe2SiCH(l)Me (rac-3) - PhMe2SiCH(NH 2)Me (rac-4) ~ PhMe2SiCH[N(H)C(O) 
CH 2 Ph]Me ( rac-5); total yield 41% ). Enantioselective enzymatic hydrolysis of rac-5, catalyzed by 
immobilized penicillin G acylase (E.C. 3.5.1.11) from Escherichia coli 5K (pHM 12), gave (R)-(1-
aminoethyl)dimethylphenylsilane [( R )-4] in 40% yield with an enantiomeric purity of 92% ee. 
Introduction 
During our investigations on the synthesis of optically active organosilicon 
compounds by use of stereoselective biotransformations, both whole microbial cells 
[1-6] and free enzymes [7] were used as biocatalysts (for recent reviews see refs. 
8-10). The types of reactions studied so far comprise enantioselective reductions, 
ester hydrolyses, and transesterifications. We report here the enzymatic synthesis of 
( R )-(1-aminoethyl)dimethylphenylsilane [( R }-41 starting from racemic dimethyl-
phenyl(l-(phenylacetamido )ethyl]silane ( rac-5). The optically active (1-
aminoethyl)silane ( R )-4 was obtained by a kinetic resolution of rac-5 using im-
mobilized penicillin G acylase (PGA, E.C. 3.5.1.11) from Escherichia coli 5K (pHM 
12) as biocatalyst (for a preliminary report on this reaction, see ref. 11). This type of 
enzymatic reaction ( amide hydrolysis) has not previously been used for the prepara-
tion of optically active organosilicon compounds. 
Results and discussion 
Synthesis of rac-5 
Compound rac-5 was made by a four-step route starting from (chloromethyl)di-
methylphenylsilane (1), as outlined in Scheme 1. Following a procedure described in 
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ref. 12 (in this context, see also refs. 13-15), the (chloromethyl)silane 1 was 
deprotonated by treatment with sec-butyllithium/ N, N, N ', N '-tetramethylethylene-
diamine in tetrahydrofuran to give [ ch1oro( dimethylphenylsilyl)methyl]lithium, which 
when treated with methyl iodide gave the (1-chloroethyl)silane rac-2 (yield 66% ). 
Treatment of rac-2 with sodium iodide in acetone (cf. ref. 16) gave the (1-
iodoethyl)silane rac-3 (yield 81 %; ref. 16: 78%), which was then converted into the 
corresponding (1-aminoethyl)silane rac-4 by reaction with ammonia under pressure, 
following a procedure described in ref. 16. Under optirnized reaction conditions (see 
Experimental section), rac-4 was obtained in 94% yield (ref. 16: 23-62%). In the last 
step, the [1-(phenylacetamido)ethyl]silane rac-5 was prepared by acylation of rac-4 
with phenylacetic acid using 4,6-diphenylthieno[3,4-d]-1 ,3-dioxol-2-one 5~5-dioxide 
(Steglich's reagent [17 -19]) as carboxyl activating agent (yield 82% ). 
The silane rac·5 was synthesized for the first time (total yield 41%, based on 1 
used). The precursors rac-2-rac-4 have been described previously [16], but in the 
present paper a new method for the preparation of rac-2 is described, as are 
optimized procedures for the synthesis of rac-3 and rac-4. 
Enzymatic hydrolysis of rac-5 
Preliminary experiments have shown that (R)-4 can be prepared by enantioselec-
tive hydrolysis of rac-5 with immobilized PGA as biocatalyst (Scheme 2). The 
conditions for this bioconversion were optimized by analytical·scale studies [ 11 ], on 
· CH3 H 0 
o- 1 I II -o Si-C-NH-C-CH 2 'I ~ I I -
CH 3 CH3 
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the basis of which the following conditions were chosen for a conversion of rac-5 on 
a preparative scale (225 mg scale): 1.8 1 of 0.1 M potassium phosphate buffer/ 
dimethyl sulfoxide (99.5 /0.5, v jv) as reaction medium, pH 7 .5, temperature 37 ° C, 
substrate concentration 0.42 mmoljl, 90 g immobilized PGA [100 U jg, related to 
the hydrolysis of penicillin G; acrylic beads (Eupergit C)], reaction time 3 hours 
(about 45% conversion of rac-5). After termination of the enzymatic hydrolysis by 
addition of ethyl acetate, the product ( R )-4 was separated from the unchanged 
substrate and isolated in 40% yield (related to rac-5) with an enantiomeric purity of 
92% ee. The unchanged starting material (S)-5 was recovered in 50% yield (related 
to rac-5). 
The absolute configuration and enantiomeric purity of the product ( R )-4 were 
determined, after derivatization with ( S )-a-methoxy-a:-trifluoromethylphenylacetic 
acid [(S)-MTPA], by 1H NMR spectroscopic sturlies (see ref. 20) and GLC, 
respectively. For comparison, a 1:1 mixture of the diastereomeric [(S)-MTPA] 
arnides of ( R )-4 and ( S )-4 was prepared from rac-4. These amides were obtained by 
reaction of 4 with (S)-MTPA in the presence of N,N'-dicyclohexylcarbodiimide 
and a catalytic amount of ( 4-dimethylamino )pyridine. 
The results described here demonstrate that enantioselective biotransformations, 
with immobilized enzymes as biocatalyst, may be useful for the synthesis of 
optically active organosilicon compounds on a preparative scale. 
Experimental 
( a) Chemical syntheses 
All reactions were performed in dried solvents under dry nitrogen. Melting points 
were determined with a Reichelt Thermovar apparatus (without correction). 1H and 
13C NMR spectra were recorded on a Bruker AM-400 spectrometer operating at 
400.1 and 100.6 MHz, respectively. Chemical shifts (ppm) were measured relative to 
the intemal standard Si(CH3 ) 4 CH and 13C, ~ 0). Assignment of the 13C data was 
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assisted by DEPT experiments. 19 F and 29Si NMR spectra were recorded on a 
Bruker AC-200 spectrometer operating at 188.3 and 39.8 MHz, respectively. Chem-
ical shifts (ppm) were measured with respect to those of CFC1 3 e9F, o 0) or 
Si(CH 3 ) 4 ( 29Si, 8 0) as external standard. Mass spectra were obtained with a 
Finnigan MAT 8430 mass spectrometer (EI MS, 70 eV)~ the m/= values given refer 
. l 12 14 16 28 . 35 127 to the tsotopes H, C, N, 0, St, Cl and I. 
(Chloromethyl)dimethylphenylsi/ane ( 1) 
Synthesis according to ref. 14. 
rac-( 1-Chloroethyl)dimethylphenylsilane (rac-2) 
A 1.4 M solution (164 ml) of sec-butyllithium in cyclohexane/ isopentane (92/8, 
v jv; 0.23 mol sec-butyllithium) and 24.1 g (0.21 mol) N, N, N ', N '-tetramethylethyl-
enediamine were successively added dropwise to a stirred solution of 40.0 g (0.217 
mol) 1 in 260 ml of THF at - 78 o C during periods of 1.5 h and 20 min, 
respectively. After 1 h stirring at - 78 o C the mixture was allowed to wann to 
-55 ° C and a solution of 41.2 g (0.29 mol) of methyl iodide in 70 ml of THF was 
added dropwise during 1 h. When the additionwas complete, stirring was continued 
for 40 min at -40 ° C and an additional 16 h at room temperature. The mixturewas 
then added carefully (ice cooling) to 700 ml of saturated aqueous NH 4 Cl. The 
organic phase was separated and the aqueous layer extracted three times wi th 350 
ml portians of diethyl ether. The combined organic extracts were washed with water 
and dried over Na 2S04 , and the solvent was then removed in vacuo and the residue 
fractionally distilled to yield 28.3 g (66%) of a colourless liquid. b.p. 76 o C/6 Torr 
(ref. 16: b.p. 90-97°C/4 Torr). 1H NMR (CDC1 3): S 0.40 (s, 3H; SiCH 3), 0.41 (s, 
3H; SiCH3 ), 1.46 (d, 'l(HH) 7.6 Hz. 3H; CCH 3 ), 3.53 (q, :Y(HH) 7.6 Hz, 1H: 
SiCH(Cl)C), 7.4-7.6 (m, 5H; SiC6 H 5 ). 13C NMR (CDC1 3 ): 8 -6.1 (SiCH 3 ), -5.0 
(SiCH 3 ), 20.1 (CCH 3 ), 45.0 (SiCH(Cl)C). 127.9 (C"p SiC6 H 5 ), 129.6 (CP. SiC6 H 5 ). 
134.2 (C0 , SiC6 H 5 ), 135.7 (Ci, SiC6 H 5 ). MS: m/z 198 (1%. M+). 135 (100%. 
M+- CH(Cl)CH 3 ). Anal. Found: C 60.4; H 7.5. C 10 H 15 C1Si (198.8) calc.: C 60.43; 
H 7.61 %. 
rac-( 1-lodoethy/)dimethylphenylsi/ane (rac-3) 
The procedure was as described in ref. 16. Sodium iodide (83.9 g; 0.56 mol) was 
added to a solution of 40.0 g (0.20 mol) rac-2 in 200 ml of acetone and the mixture 
was stirred under reflux for 11 days. It was then cooled to room temperature, 200 ml 
of water were added and the mixture extracted three times with 250 ml portians of 
diethyl ether. The combined organic extracts were dried over Na 2S04 , the solvent 
was removed in vacuo, and the residue fractionally distilled to yield 47.4 g (81%) of 
a colourless liquid, b.p. 66°Cj0.~ Torr (ref. 16: ~ield 78%, b.p. 130°C/10 Torr). 1H 
NMR (CDCI 3 ): 8 0.49 (s, 6H; StCH 3 ), 1.83 (d, Y(HH) 7.8 Hz, 3H; CCH 3 ), 3.41 (q, 
)(HH) 7.8 Hz, 1 H~ SiCH(l)C), 7.4-7.6 (m, 5H; SiC6 H 5 ). 11C NMR (CDCJ 3 ): 8 
-5.0 (SiCH 3 ), -3.1 (SiCH 3 ), 11.7 (CCH 3), 22.2 (SiCH(I)C). 127.9 (Cn1' SiC6 H 5 ), 
129.6 (CP, SiC6 H 5 ), 134.1 (C0 , SiC6 H 5 ), 135.8 (Cj, SiC(lH 5 ). MS: m/z 290 (2%, 
M+), 135 (100%, M+- CH(I)CH 3 ). C 10 H 15 1Si (290.2). 
rac-( 1-Aminoethyl)dimethy/phenylsilane (rac-4) 
The procedure was a modification of that described in ref. 16. A 250 ml glass 
tube charged with 12.1 g (41.7 mmol) rac-3 and ca. 180 ml of liquid ammonia was 
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placed in a 250 ml autoclave. When the autoclave was heated to 135 o C a pressure 
of 70-75 bar was reached. The autoclave was kept for 2.5 h under these conditions 
and then allowed to cool to room temperature. After evaporation of the excess of 
ammonia, 30 ml of a 6 N aqueous NaOH solution were added and the mixturewas 
extracted four times with 70 ml portions of diethyl ether. The combined organic 
layers were dried over Na 2S04 , the solvent was removed in vacuo, and the residue 
(consisting of a mixture of a white solid and a colourless oil) was fractionally 
distilled to yield 7.00 g (94%) of a colourless liquid, b.p. 82°C/O.l Torr (ref. 16: 
yield 23-62%, b.p. 90-130 ° C/2 Torr), which partly crystallized at room tempera-
ture, to give a solid of m.p. 44-51 o C. 1H NMR (CDC1 3): ß 0.32 (s, 3H; SiCH 3), 
0.33 (s, 3H; SiCH 3 ), 1.15 (d, 3J(HH) 7.4 Hz, 3H; CCH 3 ), 2.39 (broad 's', 2H; NH 2 ), 
2.53 (q, 3J(HH) 7.4 Hz, 1H; SiCH(N)C), 7.3-7.6 (m, 5H; SiC6 H 5 ). 13C NMR 
(CDC1 3 ): ß -5.9 (SiCH 3), -5.6 (SiCH 3 ), 19.6 (CCH 3 ), 36.0 (SiCH(N)C), 127.9 
(Cm, SiC6 H 5 ), 129.2 (CP, SiC6H 5 ), 134.1 (C0 , SiC6 H 5 ), 136.9 (Ci, SiC6H 5 ). 29Si 
NMR (CDC1 3 ): -0.4. MS: m/z 179 (3%, M+), 44 (100%, H 2N=C(CH 3 )H+). 
C10 H17NSi (179.3). 
rac-Dimethylphenyl{ 1-(phenylacetamido)ethyl]silane (rac-5) 
A mixture of 1.00 g (3.06 mmol) 4,6-diphenylthieno[3,4-d]-1,3-dioxol-2-one 5,5-
dioxide (Steglich's reagent), 0.41 g (3.01 mmol) phenylacetic acid and 0.24 g (3.03 
mmol) pyridinein 25 ml of dichloromethane was stirred for 2 h at room tempera-
ture. Subsequently, 0.31 g (3.06 mmol) triethylamine were added, the solution 
turning orange-red. After 10 min stirring, a solution of 0.45 g (2.51 mmol) rac-4 in 
15 m1 of dichloromethane was added dropwise. Stirring was continued for 2 h, 
giving a yellow solution. The mixture was extracted twice with 30 ml portions of 
20% aqueous citric acid, three times with 50 ml portians of saturated aqueous 
N aHC03 solution, then again with 30 ml of 20% aqueous citric acid solution, and 
finally with 30 ml of water. The organic layer was dried over MgS04 and the solvent 
removed in vacuo. Recrystallization of the remaining solid from acetonitrile at 
-20 ° C gave 0.61 g (82%) of white needles, m.p. 85 ° C. 1H NMR (CDC1 3): 8 0.19 
(s, 3H; SiCH 3), 0.24 (s, 3H; SiCH 3 ), 1.02 (d, 3J(HH) 7.5 Hz, 3H; CCH 3 ), 3.39 and 2 3 3 3.54 (AB system, J(HH) 15.9 Hz, 2H; CCH 2C), 3.73 (dq, J(HH) 7.5 Hz, J(HH) 
9.6 Hz, 1H; SiCH(N)C), 5.0-5.1 (m, 1H; NH), 7.1-7.4 (m, lOH; SiC6 H 5 , CC6H 5 ). 13C NMR (CDC1 3): 8 -5.4 (SiCH 3), 16.4 (CCH 3), 34.4 (SiCH(N)C), 44.1 
(CCH 2C), 127.3, 128.0, 129.0, 133.8, 135.1 and 135.6 (SiC6 H 5, CC6 H 5), 170.3 (CO). 29Si NMR (CDC1 3 ): o -1.7. MS: m/z 297 (56%, M+), 135 (100%, M+-
CH[N(H)C(O)CH 2C6H 5]CH 3). Anal. Found: C 72.7; H 7.9; N 4.7. C 18 H 23N0Si 
(297.5) calc.: C 72.68; H 7.79; N 4.71 %. 
Preparation of the [(S)-MTPA] amides of 4, determination of their absolute 
configuration, and their separation by gas chromatography 
A solution of 9.0 mg (50 p.mol) 4 (chemically prepared racemic 4 or the 
biotransformation product 4) in 0.5 ml dichloromethane was added at room 
temperature to a stirred mixture of 14.1 mg (60 p.mol) (S)-a-methoxy-a-trifluoro-
methylphenylacetic acid [(S)-MTPA], 18.6 mg (90 p.mol) N,N'-dicyclohexylcarbo-
diimide and 1-2 mg ( 4-dimethylamino )pyridine in 4 ml of dichloromethane. Stirring 
was continued until the reaction was complete [monitored by thin-layer chromatog-
raphy (pre-coated plastic-backed plates, silica gel 60 F254 , Merck 5735; dichloro-
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methane; diethyl ether (1/L v jv)]. The suspension was centrifuged and the super-
nataut liquid isolated with a syringe and the solvent evaporated in vacuo. The 
residue was purified by preparative layer chromatography [pre-coated glass plates. 
silica gel 60, Merck 13895; dichloromethane/ diethyl ether (1/1. v jv)]. The result-
ing mixture of the diastereomeric [(S)-MTPA] amides of (R)-4 and (S)-4 was 
dissolved in benzene-d6 and then analyzed by NMR spectroscopy. The absolute 
configuration of the Si-C*H(NHR)-C skeleton of the [(S)-MTPA] amides of 
( R )-4 and ( S )-4 was assigned by the correlation n1ethod described in ref. 20. 
[(Sj-MTPA] amide of (R)-4. 1 H NMR (C6 D6 : 8 0.15 (s! 3H; SiCH 3 ). 0.21 (s, 
3H: SiCH_:J. 0.91 (d, :Y(HH) 7.5 Hz, 3H~ CCH 3 ). 3.00 (q. S.,(HF) 1.5 Hz. 3H: 
OCHJ), 3.84 (q, :Y(HH) 7.5 Hz, lH; SiCH(N)C), 6.3-6.4 (m, 1H: NH), 7.0--7.7 (m. 
lOH: SiC6 H 5 , CC(1H 5 ). 19 F NMR (C6 D6 ): 8 -68.7. 
[(Sj-MTPA} amide of (S)-4. 1H NMR (C6 D(1: 8 0.10 (s. 3H; SiCH 3 ), 0.11 (s. 
3H; SiCH~). 0.97 (d, )(HH) 7.5 Hz, 3H; CCH 3 ), 3.05 (q. )(HF) 1.6 Hz. 3H; 
OCH 1 ). 3.78 (q, )(HH) 7.5 Hz, 1H; SiCH(N)C), 6.2--6.3 (n1, 1H: NH). 7.0-7.7 (n1. 
. . 19 
lOH: StC6 H 5 • CC6 H 5 ). F NMR (C6 D6 ): 8 -68.9. 
For separation of the [(S )-MTPA] an1ides of 4 by gas chrotnatography a 
Chrompack instrument (model 436) was used [capillary column Cp-Sil-5 CB, 10 m, 
0.25 mm; split injection, 270 o C; carrier gas hydrogen; temperature programmme 
150-200 o C (6 o jmin); FID, 300 o C; retention time 3. 7 (derivative of ( S )-4) and 4.0 
min, respectively (derivative of ( R)-4)]. The samples used for these GLC studies 
were obtained as follows: After derivatization of chemically or enzymatically 
prepared 4 with ( S )-MTPA by the procedure described above, the resulting reaction 
mixture was centrifuged and 1 J ..d of the supernatant was analyzed directly \vithout 
further purification. 
(h) Bioconversion 
Immobilized penicillin G acylase (90 g; 9000 U. related to the hydrolysis of 
penicillin G) from Escherichia coli 5 K (pHM 12) [E.C. 3.5.1.11; immobilized on 
Eupergit C (Röhm, Germany)] was suspended at 37 o C in 1.8 I of 0.1 M potassiun1 
phosphate buffer (pH 7.5). The reaction was started by adding a solution of 225 mg 
(756 J.Lmol) rac-5 in 9 ml of DMSO to the mechanically stirred enzyme suspension. 
After 3 h stirring the reaction was terminated by addition of 100 Inl of ethyl acetate 
and subsequent removal of the enzyme preparation by filtration (Büchner funnel). 
The biocatalyst was washed successively three times with 200 ml of ethyl acetate 
and three tin1es with 300 ml of the buffer solution. The organic and aqueous 
solutions were combined and the aqueous layer was adjusted to pH < 3 with 6 lv 
hydrochloric acid. The organic 1ayer was separated and washed twice with ca. 200 
ml of 6 N aqueous KOH solution to remove the DMSO, phenylacetic acid, and 
HCI. The organic extract was dried over Na 2S04 and the solvent evaporated; the 
solid crude product was purified by recrystallization from acetonitrile at - 20 o C to 
yield 112 mg (50%, related to rac-5) of the unchanged substrate 5. The acidic 
aqueous layer containing the hydrochloride of the biotransformation product was 
adjusted to pH 10 with 6 N aqueous KOH solution and then extracted with 800 ml 
of ethyl acetate. The organic layer was washed twice with ca. 200 ml of 6 N aqueous 
KOH solution to remove the DMSO and then dried over Na 2S04 . After removal of 
the solvent in vacuo the crude product was purified by Kugelrohr distillation 
(80 o CjO.l Torr) to give 54.3 mg (40%. re1ated to rac-5) of ( R )-4 as a colourless 
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liquid which partly crystallized at room temperature to give a solid of m.p. 78 ° C. 
The spectroscopic properties of the product were identical with those of chemically 
prepared rac-4 (see above). 
1H NMR spectroscopic sturlies and GLC analyses of the biotransformation 
product, after derivatization with (S}-MTPA (see above), revealed the (R)-config-
uration for the excess enantiomer of 4 and an enantiomeric purity of 92% ee. 
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